Physician profile
Heather Lo
NPI 1336926260
$627.52
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $253.28 | 2024 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $75.33 | 2024 | Trelegy Ellipta, Rotarix, Bexsero |
| Novo Nordisk INC | $64.24 | 2024 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $54.92 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $52.92 | 2024 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.86 | 2024 | Jardiance |
| Esperion Therapeutics, INC. | $23.34 | 2024 | Nexletol |
| Exact Sciences Corporation | $22.61 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.09 | 2024 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.